drugset / Trial / NCT00785759
Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers
Phase 2
Completed
78 enrolled
GE Healthcare
Hvidovre University Hospital · collabMedpace, Inc. · collabi3 Statprobe · collab
NaSingle-groupOpen-labelDiagnostic
Summary
Study to Assess Brain Uptake and Safety of AH110690 (18F) Injection in Subjects with Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers.
Timeline
- Start
- 2008-09
- Primary completion
- 2009-03
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flutemetamol | Diagnostic / imaging agent | 185 mbq | Intravenous |